The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome.
about
Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical IntegrationTreatment options for hypertension in pregnancy and puerperium.Expression of placental growth factor mRNA in preeclampsia.Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practiceAssociation of maternal hypertensive disorders with retinopathy of prematurity: A systematic review and meta-analysisRemoval of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia.Preeclampsia and Vascular Function: A Window to Future Cardiovascular Disease Risk.Ischemic placental syndrome--prediction and new disease monitoring.Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.The relationship of angiogenic factors to maternal and neonatal manifestations of early-onset and late-onset preeclampsia.Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study.
P2860
Q26796661-D932DFAB-37BA-491D-81C9-C012A7A551B3Q30244979-AB1785E9-BD53-4BCE-8039-6D26FFE0A97BQ33736940-AD68A2CD-1240-49C8-956E-C3B9FB5B4482Q35204444-554696C2-2E83-478B-BB35-2DDE67F84581Q36339840-28974525-4674-4951-B971-6846D2418A06Q36624730-6C9CB7D7-BB70-4743-AF31-235799386BA7Q36683205-9E3277FB-8523-4132-94C0-43970817F169Q38601408-83681C2F-E3FB-4DCD-97C5-8649F4B69466Q41033848-E3FEA4CA-83C6-4A40-B52D-1D9BA84D29FDQ49312791-144F4A82-5664-4267-A4A9-4A8C3C7B83AEQ54345637-F0AE6F09-D302-47AD-9294-162BC06D9C95Q55004295-3EDCAAF6-AB31-4F14-9D6F-86B77AEC8AFC
P2860
The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The course of angiogenic facto ...... eeclampsia and HELLP syndrome.
@en
The course of angiogenic facto ...... eeclampsia and HELLP syndrome.
@nl
type
label
The course of angiogenic facto ...... eeclampsia and HELLP syndrome.
@en
The course of angiogenic facto ...... eeclampsia and HELLP syndrome.
@nl
prefLabel
The course of angiogenic facto ...... eeclampsia and HELLP syndrome.
@en
The course of angiogenic facto ...... eeclampsia and HELLP syndrome.
@nl
P2093
P2860
P356
P1476
The course of angiogenic facto ...... eeclampsia and HELLP syndrome.
@en
P2093
Holger Stepan
Sarosh Rana
Wiebke Schaarschmidt
P2860
P304
P356
10.1515/JPM-2012-0248
P577
2013-09-01T00:00:00Z